Health Highlights: Nov. 7, 2022

Amid a surge of RSV, hope for new vaccines. As many as four new RSV vaccine candidates could soon be sent for review by the U.S. Food and Drug Administration, experts say, and dozens more are in testing or under development. Read more
Is surgery always necessary for chronic chest pain? A new clinical trial finds patients' overall risk of death is about the same whether they choose aggressive surgical treatment or a more conservative approach focused on medication and lifestyle changes. Read more
Paxlovid might cut odds for long COVID. A new analysis showed people treated with the drug had a 26% reduced risk of developing several long COVID conditions, including heart disease, blood disorders, fatigue and other issues. Read more
Related Posts
FDA Approves Xacduro for Difficult-to-Treat Bacterial Pneumonia
TUESDAY, May 30, 2023 (HealthDay News) -- The U.S. Food and Drug Administration...
PTSD Linked to Faster Cognitive Decline in Middle-Aged Women
WEDNESDAY, July 6, 2022 (HealthDay News) -- Posttraumatic stress disorder (PTSD)...
Living Alone Raises Americans’ Cancer Risk by Nearly a Third
THURSDAY, Oct. 19, 2023 (HealthDay News) -- People who live alone have a greater...
Un tratamiento prequirúrgico podría ser un avance contra unos letales cánceres de hígado
VIERNES, 28 de enero de 2022 (HealthDay News) -- Cuando da un diagnóstico de...
